Contralateral breast cancer after radiotherapy and hormone therapy in two cohorts of US breast cancer survivors.

Saved in:
Bibliographic Details
Title: Contralateral breast cancer after radiotherapy and hormone therapy in two cohorts of US breast cancer survivors.
Authors: Veiga LHS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. veigal@mail.nih.gov., Gierach GL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Smith SA; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Howell RM; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mille MM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Saha M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Curtis RE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Ramin C; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Bodelon C; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.; Department of Population Science, American Cancer Society, Atlanta, GA, USA., Feigelson HS; Bernard J. Tyson Kaiser Permanente School of Medicine, Pasadena, CA, USA.; Institute for Health Research, Kaiser Permanente, Denver, CO, USA., Aiello Bowles EJ; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, WA, USA., Buist DSM; Data-driven Strategies for Medicine & Biotechnology, Mercer Island, WA, USA.; University of Washington, Department of Health Systems and Population, School of Public Health, Seattle, WA, USA., Weinmann S; Kaiser Permanente Center for Health Research, Portland, OR, USA., Vo JB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Lee C; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Berrington de Gonzalez A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.; Division of Genetics & Epidemiology, The Institute of Cancer Research, London, UK.
Source: British journal of cancer [Br J Cancer] 2026 Jan; Vol. 134 (2), pp. 269-278. Date of Electronic Publication: 2025 Nov 14.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41238801
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Contralateral breast cancer after radiotherapy and hormone therapy in two cohorts of US breast cancer survivors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Veiga+LHS%22">Veiga LHS</searchLink>; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. veigal@mail.nih.gov.<br /><searchLink fieldCode="AU" term="%22Gierach+GL%22">Gierach GL</searchLink>; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Smith+SA%22">Smith SA</searchLink>; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Howell+RM%22">Howell RM</searchLink>; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Mille+MM%22">Mille MM</searchLink>; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Saha+M%22">Saha M</searchLink>; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Curtis+RE%22">Curtis RE</searchLink>; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Ramin+C%22">Ramin C</searchLink>; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bodelon+C%22">Bodelon C</searchLink>; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.; Department of Population Science, American Cancer Society, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Feigelson+HS%22">Feigelson HS</searchLink>; Bernard J. Tyson Kaiser Permanente School of Medicine, Pasadena, CA, USA.; Institute for Health Research, Kaiser Permanente, Denver, CO, USA.<br /><searchLink fieldCode="AU" term="%22Aiello+Bowles+EJ%22">Aiello Bowles EJ</searchLink>; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Buist+DSM%22">Buist DSM</searchLink>; Data-driven Strategies for Medicine & Biotechnology, Mercer Island, WA, USA.; University of Washington, Department of Health Systems and Population, School of Public Health, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Weinmann+S%22">Weinmann S</searchLink>; Kaiser Permanente Center for Health Research, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Vo+JB%22">Vo JB</searchLink>; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Lee+C%22">Lee C</searchLink>; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Berrington+de+Gonzalez+A%22">Berrington de Gonzalez A</searchLink>; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.; Division of Genetics & Epidemiology, The Institute of Cancer Research, London, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2026 Jan; Vol. 134 (2), pp. 269-278. <i>Date of Electronic Publication: </i>2025 Nov 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41238801
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41416-025-03240-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 269
    Titles:
      – TitleFull: Contralateral breast cancer after radiotherapy and hormone therapy in two cohorts of US breast cancer survivors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Veiga LHS
      – PersonEntity:
          Name:
            NameFull: Gierach GL
      – PersonEntity:
          Name:
            NameFull: Smith SA
      – PersonEntity:
          Name:
            NameFull: Howell RM
      – PersonEntity:
          Name:
            NameFull: Mille MM
      – PersonEntity:
          Name:
            NameFull: Saha M
      – PersonEntity:
          Name:
            NameFull: Curtis RE
      – PersonEntity:
          Name:
            NameFull: Ramin C
      – PersonEntity:
          Name:
            NameFull: Bodelon C
      – PersonEntity:
          Name:
            NameFull: Feigelson HS
      – PersonEntity:
          Name:
            NameFull: Aiello Bowles EJ
      – PersonEntity:
          Name:
            NameFull: Buist DSM
      – PersonEntity:
          Name:
            NameFull: Weinmann S
      – PersonEntity:
          Name:
            NameFull: Vo JB
      – PersonEntity:
          Name:
            NameFull: Lee C
      – PersonEntity:
          Name:
            NameFull: Berrington de Gonzalez A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1532-1827
          Numbering:
            – Type: volume
              Value: 134
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: British journal of cancer
              Type: main
ResultId 1